Sign in
4

Changes in Ownership

ZEVRA THERAPEUTICS, INC. Filed Acc 0001209191-15-035355

Exec VP R&D acquired 23,852 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Guenther Sven · Exec VP R&D

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2015-04-21 Conversion : show line 1 in the form +23,852 43,852 D

Table II: Derivative

3 lines
Date Transaction Shares Underlying Owned after D/I
2015-04-21 Conversion : show line 2 in the form Series A Convertible Preferred Stock −26,355 3,514 0 D
2015-04-21 Conversion : show line 3 in the form Series B Convertible Preferred Stock −16,129 2,150 0 D
2015-04-21 Conversion : show line 4 in the form Series C Convertible Preferred Stock −136,410 18,188 0 D
Loading xslF345X03/doc4.xml…